USE OF A CENTRALLY ACTING ACTH ANALOG IN THE MANUFACTURE OF A MEDICAMENT

USE OF A CENTRALLY ACTING ACTH ANALOG IN THE MANUFACTURE OF A MEDICAMENT

Disclosed is the use of: H-MetO2-Glu-His-Phe-D-Lys-Phe-X-(CH2)nCH3, wherein X is NH or O, and n is a positive integer ranging from 7 to 17 for the manufacture of a medicament having selective centrally acting nerve regeneration activity, but essentially no peripheral nerve regeneration activity. Onc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JOHANNES WILHELMUS FRANCISCUS MARIA VAN NISPEN, DAVID DE WIED
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed is the use of: H-MetO2-Glu-His-Phe-D-Lys-Phe-X-(CH2)nCH3, wherein X is NH or O, and n is a positive integer ranging from 7 to 17 for the manufacture of a medicament having selective centrally acting nerve regeneration activity, but essentially no peripheral nerve regeneration activity. Once manufactured, the medicaments may be used in the treatment of an animal suffering from central nerve degeneration or damage or may be used to determine the etiology of central versus peripheral nerve damage.